Skip to main content
OpenTrials

Clinical trial condition

Female Urogenital Diseases

Explore clinical trials studying Female Urogenital Diseases. Study availability and eligibility vary by location and protocol.

22,034 public trials 3,765 recruiting studies
Refine in advanced search Browse all conditions

Female Urogenital Diseases trial results

Recruiting

Formoterol in Diabetes

NCT07022418

Conditions
Diabetes Complications, Diabetes Mellitus, Diabetic Kidney Disease, +11 more
Locations
  • Medical University of South Carolina Charleston, South Carolina, United States
View Trial Details
Recruiting

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

NCT03193541

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • VA Long Beach Healthcare System Long Beach, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
View Trial Details
Recruiting

A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer

NCT03193515

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • UT Southwestern Medical Center at Dallas Dallas, Texas, United States
  • Kyoto University Graduate School of Medicine Kyoto, Japan
View Trial Details
Recruiting

Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)

NCT03017573

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +32 more
Locations
  • Institut Bergonie Bordeaux, France
  • Centre Oscar Lambret Lille, France
  • Centre Leon Berard Lyon, France
  • Institut Curie Paris, France
View Trial Details

Related conditions